Disposition of 800 shares by Robert Sullivan of RBC Bearings at 254.5 subject to Rule 16b-3

HRTX Stock  USD 1.18  0.04  3.28%   
Slightly above 60% of Heron Therapeuti's investor base is looking to short. The analysis of the overall investor sentiment regarding Heron Therapeuti suggests that many traders are alarmed. Heron Therapeuti's investing sentiment can be driven by a variety of factors including economic data, Heron Therapeuti's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by RBC Bearings Officer Vice President And Cfo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 800 common stock at 254.5 of RBC Bearings by Robert Sullivan on 8th of June 2024. This event was filed by RBC Bearings with SEC on 2023-11-29. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Heron Therapeuti's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Heron Therapeuti's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Heron Therapeuti Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Heron Therapeuti can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Heron Therapeuti Fundamental Analysis

We analyze Heron Therapeuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heron Therapeuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heron Therapeuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

Heron Therapeuti is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Heron Therapeuti Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Heron Therapeuti stock to make a market-neutral strategy. Peer analysis of Heron Therapeuti could also be used in its relative valuation, which is a method of valuing Heron Therapeuti by comparing valuation metrics with similar companies.

Peers

Heron Therapeuti Related Equities

ELDNEledon Pharmaceuticals   8.92   
0%
100.0%
PDSBPDS Biotechnology   4.65   
0%
52.0%
TERNTerns Pharmaceuticals   3.41   
0%
38.0%
HOOKHookipa Pharma   1.16   
13.0%
0%
DAWNDay One   1.81   
20.0%
0%
MREOMereo BioPharma   2.20   
24.0%
0%
ABOSAcumen Pharmaceuticals   2.98   
33.0%
0%
XFORX4 Pharmaceuticals   5.13   
57.0%
0%
INZYInozyme Pharma   6.09   
68.0%
0%

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.